Freedman, Ben
Boriani, Giuseppe
Glotzer, Taya V.
Healey, Jeff S.
Kirchhof, Paulus
Potpara, Tatjana S.
Article History
First Online: 6 July 2017
Competing interests
: B.F. declares that he has received speakers' fees and advisory board honoraria from Bayer Pharma AG, BMS/Pfizer, and Boehringer Ingelheim. G.B. declares that he has received honoraria (as speakers' fees) from Boston Scientific and Medtronic. T.V.G. declares that she has received a speaking honorarium from Medtronic. J.H. declares that he has received grants from Bayer, Boehringer Ingelheim, Bristol-Meyers-Squibb, and Medtronic. P.K. declares that he has received grants and personal fees from several industry companies involved in producing AF therapies (including Bayer Healthcare, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo, Medtronic, Pfizer, and Servier); grants and personal fees from AFNET, ESC, and other professional societies and academic organizations; and has patents on 'AF therapy' and 'Markers for AF' pending to the University of Birmingham, UK. T.S.P. declares no competing interests.